Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

AMT Plans to Reduce Workforce by Half to 45 Full-Time Employees

Oct. 25 (Bloomberg) -- Amsterdam Molecular Therapeutics NV plans to cut its workforce by half to 45 full-time employees and suspended the development program of its main product Glybera as further investment is no longer tenable, the company said in a statement today on its website.

Link to Company News:{AMT NA <Equity> CN <GO>}

To contact the editor responsible for this story: Fred Pals at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.